DDX11 and hepatocellular carcinoma: In multivariate assays, increased DDX11-AS1 presentation was demonstrated to be an independent poor prognostic factor for both OS and PFI, indicating that DDX11-AS1 might be a promising biomarker for the diagnosis and prognosis of HCC patients.